SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-16-535614
Filing Date
2016-04-08
Accepted
2016-04-08 16:53:03
Documents
2
Period of Report
2016-06-02

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY NOTICE AND PROXY STATEMENT d170618dpre14a.htm PRE 14A 855530
2 GRAPHIC g170618dsp045.jpg GRAPHIC 40649
  Complete submission text file 0001193125-16-535614.txt   912931
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1208
Type: PRE 14A | Act: 34 | File No.: 001-32302 | Film No.: 161563213
SIC: 3841 Surgical & Medical Instruments & Apparatus